Tyra Biosciences, Inc.
NASDAQ:TYRA · NASDAQ Global Select
-$0.72 today
Vol 1.71M · Avg 0.96M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+191.66%
Period High
$39.61
Period Low
$9.10
Latest
$28.32
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Day One Biopharmaceuticals, Inc.
DAWN
$2.22B
Nanobiotix S.A.
NASDAQ:NBTX
$1.79B
EyePoint Pharmaceuticals, Inc.
NASDAQ:EYPT
$1.13B
Savara Inc.
NASDAQ:SVRA
$1.11B
Kura Oncology, Inc.
NASDAQ:KURA
$852.23M
Geron Corporation
NASDAQ:GERN
$801.90M
Maravai LifeSciences Holdings, Inc.
NASDAQ:MRVI
$737.70M
Prime Medicine, Inc.
NASDAQ:PRME
$565.31M
Rezolute, Inc.
NASDAQ:RZLT
$494.46M
ProKidney Corp.
NASDAQ:PROK
$263.08M
What is the latest TYRA filing?
The latest filing shown is 8-K dated Jun 2, 2026.
How many recent filings does TYRA have?
Intrinsic Alpha currently shows 20 recent filings for TYRA.
Explore More
Continue the stock analysis
Jump to another research area for this company.